Zic2 synergistically enhances Hedgehog signalling through nuclear retention of Gli1 in cervical cancer cells

Aberrant activation of Hedgehog (Hh) signalling has been implicated in the pathogenesis of human cancers. However, the cognate molecular mechanisms contributing to this disregulated pathway are incompletely understood. In this study, we showed that Zic2 was frequently over‐expressed and associated w...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of pathology Vol. 225; no. 4; pp. 525 - 534
Main Authors Chan, David W, Liu, Vincent WS, Leung, Ling Yang, Yao, Kwok Ming, Chan, Karen KL, Cheung, Annie NY, Ngan, Hextan YS
Format Journal Article
LanguageEnglish
Published Chichester, UK John Wiley & Sons, Ltd 01.12.2011
Wiley
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Aberrant activation of Hedgehog (Hh) signalling has been implicated in the pathogenesis of human cancers. However, the cognate molecular mechanisms contributing to this disregulated pathway are incompletely understood. In this study, we showed that Zic2 was frequently over‐expressed and associated with high‐grade cervical cancer (p = 0.032), high levels of Gli1 (p < 0.001) and CyclinD1 (p < 0.001) by immunohistochemical and quantitative RT–PCR analyses. Further biochemical studies using luciferase reporter, co‐immunoprecipitation, subcellular fractionation and immunofluorescence analyses demonstrated that Zic2 can physically interact with Gli1 and retain it in the nucleus, which in turn increases Gli‐mediated transcriptional activity. Gain‐ and loss‐of‐function analyses of Zic2 showed that Zic2 could increase Hh signalling activity, cell proliferation and anchorage‐independent growth ability in cervical cancer cells. Conversely, deletion of the zinc finger domain at C‐terminus of Zic2 significantly abrogated its interaction with Gli1, the retention of Gli1 in the nucleus, effects on Hh signalling activity and oncogenic properties in cervical cancer cells. Our findings suggest that Zic2 is a positive modulator increasing Gli1 transcriptional and oncogenic activity by retaining Gli1 in the nucleus of cervical cancer cells. Copyright © 2011 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
Bibliography:Supporting Information: Figure S1. Semi-quantitative RT-PCR analysis revealed that the up-regulation of Zic2 but not Zic1 or Zic3 was associated with the high level of the main Hh effector, Gli1.Supporting Information: Figure S2. The growth of cervical cancer cells depends on Hh signalling activity. XTT cell proliferation assays showed that the growth of cervical cancer cells (Hela, SiHa, CaSki and C33A) was significantly suppressed upon treatment with KAAD-cyclopamine at various doses.Supporting Information: Legends to Figure S1 to S2
istex:CC0A81ADEE5A3F2DA14E4A37675BD5FD361A717B
ark:/67375/WNG-0L8859PB-V
ArticleID:PATH2901
No conflicts of interest were declared.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0022-3417
1096-9896
DOI:10.1002/path.2901